Good MorningEquities markets fell on Wednesday as bond yields come back into focus. The yield on the 10-year Treasury rose more than 5 basis points to close at the second-highest level in over a year as investors continue to bet on rising inflation. The rise in the bond yield implies the FOMC will have to alter policy sooner rather than later and that could be a bad thing for the stock market. A more hawkish FOMC outlook could crimp the growth outlook and would likely spark profit-taking if not a deeper correction.
In economic news, both the ISM Services index and the ADP Employment figures were below expectation. The ADP figure showed jobs were gained in February but a lower rate than was expected. The ISM data shows the services sector continues to grow but also at a slower rate than was expected.
Featured: Top Stock Research Firm Offers FREE Trade Alerts (No Credit Card Needed) (Gorilla Trades) 
|
Stocks | | | Sometimes a company simply has limited growth prospects, fundamental flaws, or has simply fallen out of favor with the market. Here we highlight three downtrodden stocks whose performance could get significantly worse Read the Full Story |
|
From Our PartnersMy #1 EV battery stock just jumped from $12 to over $56 in just 26 days. That's a 317% profit! Now I'm revealing urgent details on my brand-new EV battery Pre-IPO. | | Just click here for urgent details. |
|
Markets | | | Stocks are drifting lower in morning trading on Wall Street Tuesday, giving back some of their big gains from a day earlier.
The S&P 500 was down 0.3% after earlier flipping between small gains and losses. A day before, it leaped 2.4% for its best performance since June, nearly e... Read the Full Story |
|
Markets | | | Stocks are drifting in early trading on Wall Street Tuesday, taking a pause from their sharp seesaw ride triggered by a swift rise in interest rates the last few weeks.
The S&P 500 was 0.1% lower after flipping between small gains and losses in the first half hour of trading. A d... Read the Full Story |
|
From Our PartnersForget stock options, try this NEW method...
Lightning fast & can cost as Little as 5¢ or even 1¢...
Learn more here! | | | | Continue Reading |
|
Stocks | | |
Can you think of an industry that was hit harder during the onset of the pandemic more than resorts & casinos? Casino stocks were pummeled throughout 2020 as they reported sharp declines in revenue and earnings while people were stuck at home and practicing social distancing. It was hard for t... Read the Full Story |
|
Markets | | | Kohl's reported mixed results for its fiscal fourth quarter, delivering a 30% increase in profits but a 10% drop in sales.
Results handily beat Wall Street estimates. Online sales growth remained strong, up 22% for the latest quarter, and accounted for 42% of net sales.
... Read the Full Story |
|
From Our PartnersForget stock options, try this NEW method...
Lightning fast & can cost as Little as 5¢ or even 1¢...
Learn more here! | | | | Continue Reading |
|
Politics | | | VATICAN CITY — The Vatican is defending Pope Francis’ decision to go ahead with his trip to Iraq this weekend despite rising coronavirus infections there and concerns about crowds wanting to see him.
The Vatican says health care precautions are being taken and the trip is an “act of l... Read the Full Story |
|
Markets | | | In a deal to jettison itself from under bankruptcy protection, Hertz said Tuesday that it may sell a controlling stake in the company to two investment firms for $4.2 billion.
Knighthead Capital Management and Certares Opportunities will have the chance to buy the entire reorganized ... Read the Full Story |
|
Markets | | | The folks over at insurance tech name Lemonade (NYSE: LMND) are quickly learning that what goes up, almost always comes down. Despite jumping more than 300% from last November through the start of January, Read the Full Story |
|
Markets | | | After correcting more than 36% and entering a deep bear-market many traders and investors are wondering if Ethereum’s (ETH) run is over. Well, we’re here to tell you there are fundamental forces at play that suggest Ethereum’s bull market is far from over. Read the Full Story |
|
Markets | | | For anyone who thought the mall-facing retailer was in a state of hopeless decline, American Eagle (NYSE:AEO) has a real surprise for you. Actually, it has two surprises: beats in both earnings and revenue. Read the Full Story |
|
The Early Bird Stock Of The Day Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania. | | View Today's Stock Pick |
|
